Around the world, conversations about psychedelic medicine are starting to infiltrate everyday life. Major universities and nonprofits are funding groundbreaking research, private companies are raising hundreds of millions of dollars, and an entire new way to approach mental health is starting to materialize. However, despite much of this progress, psychedelic drugs are still viewed with […]
This morning, Monday May 24th, Enveric Biosciences (NASDAQ: ENVB) announced that it has entered an agreement to acquire privately held biotechnology company MagicMed Industries. MagicMed has a state-of-the-art facility at the University of Calgary, which it uses to perform extensive R&D on naturally occurring psychedelic molecules. Their focus is the discovery and early development of […]
To learn more about what the fund is building and where it sees the future going in the psychedelic space, we sat down with Noetic’s three managing partners: Michael Franks, Sa’ad Shah and Naseem Saloojee.
One aspect of psychedelic and plant-based medicine that often gets overlooked by for-profit interests is the fact that many of these compounds are rooted in indigenous communities. For instance, the peyote ceremonies that help so many with PTSD and depression are based on traditional treatments that have been practiced in rare parts of the world […]